Citigroup’s Danimer Scientific, Inc. DNMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-26
Closed -$463 6031
2024
Q3
$463 Sell
26
-1,331
-98% -$23.2K ﹤0.01% 5488
2024
Q2
$32.8K Buy
1,357
+823
+154% +$25.6K ﹤0.01% 4812
2024
Q1
$23.3K Buy
534
+199
+59% +$8.24K ﹤0.01% 4985
2023
Q4
$13.7K Buy
335
+303
+947% +$16.5K ﹤0.01% 5111
2023
Q3
$2.61K Sell
32
-669
-95% -$60.7K ﹤0.01% 4896
2023
Q2
$66.8K Buy
701
+640
+1,049% +$82.1K ﹤0.01% 4471
2023
Q1
$8.4K Sell
61
-39
-39% -$3.57K ﹤0.01% 4804
2022
Q4
$7.18K Sell
100
-81
-45% -$7.66K ﹤0.01% 4950
2022
Q3
$22K Sell
181
-182
-50% -$32.4K ﹤0.01% 4723
2022
Q2
$66K Buy
363
+25
+7% +$4.54K ﹤0.01% 4414
2022
Q1
$79K Sell
338
-1,108
-77% -$224K ﹤0.01% 4529
2021
Q4
$493K Buy
1,446
+1,150
+389% +$633K ﹤0.01% 3804
2021
Q3
$193K Buy
296
+107
+57% +$78.7K ﹤0.01% 4131
2021
Q2
$190K Buy
189
+105
+125% +$105K ﹤0.01% 4260
2021
Q1
$126K Buy
84
+41
+95% +$66.6K ﹤0.01% 4253
2020
Q4
$40K Buy
+43
New +$23.1K ﹤0.01% 6205

Other funds holding DNMR

Citigroup's DNMR Position: Q4 2024 in Review

Citigroup sold out of Danimer Scientific, Inc. (DNMR) in Q4 2024, closing a stake of 26 shares — an estimated $463 sold.

Citigroup first reported a position in DNMR in Q4 2020 and held it in 16 quarters. The position peaked at $493K in Q4 2021. 3 funds tracked by Wall St. Rank hold DNMR as of Q4 2024.

  • Citigroup reported no remaining Danimer Scientific, Inc. position as of Q4 2024 after selling out during the quarter.
  • Citigroup sold 26 Danimer Scientific, Inc. shares in Q4 2024, an estimated $463.
  • Citigroup first reported a position in Danimer Scientific, Inc. in Q4 2020 and held it in 16 quarters.
  • Citigroup's Danimer Scientific, Inc. position peaked at $493K in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2024.

Based on Citigroup's 13F filing for Q4 2024, filed 12 Feb 2025.